Literature DB >> 19411833

Wnt/beta-catenin signaling pathway may regulate cell cycle and expression of cyclin A and cyclin E protein in hepatocellular carcinoma cells.

Xinhong Wang1, Xiangwei Meng, Xun Sun, Mingna Liu, Shanling Gao, Jing Zhao, Fenghua Pei, Hongying Yu.   

Abstract

Wnt/beta-catenin signaling pathway and cell cycle play the key roles during the genesis and development of hepatocellular carcinoma (HCC). The cytoplasmic protein beta-catenin is a multifunctional protein and a central molecule in the Wnt signaling pathway. Cell cycle is regulated by a a series of regulatory factors. Current researches indicated that expression of cyclin D1 and c-myc decreased after silencing beta-catenin gene in HCC, but it is unclear if other cyclins are affected. To determine the relation, small interference RNA(siRNA) against beta-catenin was transfected into HCC cell line HepG(2), and cell cycle and cyclin A and cyclin E protein expression were detected. We demonstrated that cell cycle was arrested in G(0)/G(1) at 72 h after the transfection and with the time passing, the cell cycle began to transfer from G(0)/G(1) to G(2)/M through S and had a trend to revert at 96 h. In addition, beta-catenin protein expression was decreased at both 72 and 96 h, although the level was slightly higher at 96 h than that at 72 h. However, cyclin A and cyclin E protein expression increased at 72 h and decreased at 96 h. These findings suggest that silencing beta-catenin gene may induce the changes of cell cycle and cyclin A and cyclin E expression. Wnt/beta-catenin signaling pathway probably takes part in the genesis and development of HCC through regulating cell cycle and the expression of cyclin A and cyclin E.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411833     DOI: 10.4161/cc.8.10.8489

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  17 in total

1.  α-catenin. A tumor suppressor beyond adherens junctions.

Authors:  Yutong Sun; Jinsong Zhang; Li Ma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Lahousse; Hu-Hua Hong; Tai-Vu Ton; Tiwanda Masinde; Scott S Auerbach; Kevin Gerrish; Pierre R Bushel; Keith R Shockley; Shyamal D Peddada; Robert C Sills
Journal:  Toxicol Pathol       Date:  2011-05-13       Impact factor: 1.902

3.  The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma.

Authors:  Cong-Jun Wang; Lin Tang; Dong-Wei Shen; Chao Wang; Qiong-Ying Yuan; Wei Gao; Yong-Kun Wang; Rong-Hua Xu; Hui Zhang
Journal:  Mol Biol Rep       Date:  2013-10-24       Impact factor: 2.316

4.  Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.

Authors:  Chun-Yao Li; Yu-Yan Pang; Hong Yang; Jia Li; Hai-Xia Lu; Han-Lin Wang; Wei-Jia Mo; Lan-Shan Huang; Zhen-Bo Feng; Gang Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

5.  Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization.

Authors:  Etay Ziv; Hooman Yarmohammadi; F Edward Boas; Elena Nadia Petre; Karen T Brown; Stephen B Solomon; David Solit; Diane Reidy; Joseph P Erinjeri
Journal:  J Vasc Interv Radiol       Date:  2017-01-24       Impact factor: 3.464

Review 6.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.

Authors:  Linda S Steelman; William H Chappell; Stephen L Abrams; Ruth C Kempf; Jacquelyn Long; Piotr Laidler; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Franca Stivala; Maria C Mazzarino; Marco Donia; Paolo Fagone; Graziella Malaponte; Ferdinando Nicoletti; Massimo Libra; Michele Milella; Agostino Tafuri; Antonio Bonati; Jörg Bäsecke; Lucio Cocco; Camilla Evangelisti; Alberto M Martelli; Giuseppe Montalto; Melchiorre Cervello; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

7.  Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma.

Authors:  Xiao-Dong Liang; Yue-Chu Dai; Zhao-Yun Li; Mei-Fu Gan; Shi-Rong Zhang; Hong-Sheng Lu; Xue-Quan Cao; Bei-jia Zheng; Ling-Fen Bao; Dan-Dan Wang; Li-Ming Zhang; Sheng-Lin Ma
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

8.  WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.

Authors:  Ren-Jun Hsu; Jar-Yi Ho; Tai-Lung Cha; Dah-Shyong Yu; Chieh-Lin Wu; Wei-Ping Huang; Pauling Chu; Ying-Hsin Chen; Jiann-Torng Chen; Cheng-Ping Yu
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

9.  Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma.

Authors:  Bo Qu; Bing-Rong Liu; Ya-Ju DU; Jing Chen; Yan-Qiu Cheng; Wei Xu; Xin-Hong Wang
Journal:  Oncol Lett       Date:  2014-01-27       Impact factor: 2.967

10.  The roles of Notch3 on the cell proliferation and apoptosis induced by CHIR99021 in NSCLC cell lines: a functional link between Wnt and Notch signaling pathways.

Authors:  Chunyan Li; Siyang Zhang; Yao Lu; Ying Zhang; Enhua Wang; Zeshi Cui
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.